Relaxin levels corrlelated to IVF/ET pregnancy success
AssigneeThe Regents of the University of California
InventorsDennis R. Stewart, Catherine A. VandeVoort
Life of this patent
Estimating the term…
Abstract
A method of determining the probability of an in vitro fertilization (IVF) or embryo transfer (ET) method being successful is disclosed. Relaxin can be measured directly in the serum or indirectly by culturing granulosa lutein cells extracted from the patient as part of an IVF/ET procedure. A method of enhancing the rate of a successful pregnancy resulting from an IVF/ET procedure is also disclosed whereby relaxin is administered and/or endogenous relaxin levels are enhanced by varying convention IVF/ET procedures.
Claims2
A method of determining a probability of successful implantation with an ovarian stimulation in vitro fertilization and embryo transfer procedure, comprising:
- determining a relaxin level in a serum sample obtained from a patient who has undergone an ovarian stimulation in vitro fertilization and embryo transfer procedure;
- and
- determining a probability of successful implantation based on the patient's determined relaxin level;
- wherein a lower determined relaxin level relative to a standard relaxin level is associated with a decreased probability of successful implantation.
Dependencies are inferred from the claim text.